Advertisement

Topics

Oragenics Company Profile

14:26 EST 21st November 2017 | BioPortfolio

Oragenics is a publicly held biopharmaceutical company trading on the American Stock Exchange under the symbol ONI. The company is located in Progress Corporate Park at 13700 Progress Boulevard in Alachua, Florida, approximately 15 miles from the campus of the University of Florida in Gainesville. Our corporate strategy is aimed at adding value to novel technologies and products sourced from innovative research at the University of Florida and other academic centers. Our aim is to develop products through human proof-of-concept (Phase I or II of the FDA's regulatory process) prior to partnering with major pharmaceutical, biotechnology or healthcare product firms for advanced clinical development and commercialization.

Location

13700 Progress Boulevard
Alachua
Florida
32615
United States of America

Contact

Phone: 386.418.4018
Fax: 386.418.1660
Email: info@oragenics.com


News Articles [10 Associated News Articles listed on BioPortfolio]

Oragenics starts AG013 dosing in Phase II trial to treat oral mucositis

US-based antibiotics developer Oragenics has started dosing patients in a Phase II clinical trial of AG013 for the treatment of oral mucositis (OM).

Oragenics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 15062017] Prices from USD $350

Oragenics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Oragenics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report inc...

Oragenics Doses First Patient In Phase II Clinical Trial Of AG013 For Oral Mucositis

  Life Sciences Jobs   ...

XFRA UAVN: AUSSETZUNG/SUSPENSION

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL ORAGENICS IN...

Oragenics, Inc. Regains Compliance with NYSE American Continued Listing Standards

Florida-based biopharmaceutical company Oragenics, Inc. (NYSE American: OGEN) (the “Company”) today announced receipt of notification from the NYSE American LLC (the “Exch...

Oragenics to Present at the 19th Annual Rodman & Renshaw Global Investment Conference

Oragenics, Inc. (NYSE MKT:OGEN), a leader in the development of novel antibiotics against infectious diseases and innovative treatments for oral mucositis, today announced that it...

Oragenics Doses First Patient in Phase 2 Clinical Trial of AG013 for Oral Mucositis

Oragenics, Inc. (NYSE MKT: OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, today announced that the ...

Oragenics Announces Completion of Second Closing of $3.0 Million Preferred Stock Private Placement

Oragenics, Inc. (NYSE MKT:OGEN), a clinical stage biotechnology company, today announced that it has completed the second closing contemplated by the previously disclosed securiti...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Oragenics

Oragenics is a publicly held biopharmaceutical company trading on the American Stock Exchange under the symbol ONI. The company is located in Progress Corporate Park at 13700 Progress Boulevard in Ala...

Oragenics, Inc.

Oragenics, Inc. biopharmaceutical company is engaged in developing proprietary technologies, some of which are being commercialized and sold in the over-the-counter consumer ...

More Information about "Oragenics" on BioPortfolio

We have published hundreds of Oragenics news stories on BioPortfolio along with dozens of Oragenics Clinical Trials and PubMed Articles about Oragenics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oragenics Companies in our database. You can also find out about relevant Oragenics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record